These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33221227)
1. Radionuclide Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis: Different Sensitivity in Early-Onset V30M Mutation? Rodrigues P; Dias Frias A; Gouveia P; Trêpa M; Fontes Oliveira M; Costa R; Reis H; Amorim I; Palma P; Cyrne Carvalho H; Torres S JACC Cardiovasc Imaging; 2021 May; 14(5):1072-1074. PubMed ID: 33221227 [No Abstract] [Full Text] [Related]
5. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273 [TBL] [Abstract][Full Text] [Related]
6. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285 [TBL] [Abstract][Full Text] [Related]
7. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation. Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341 [No Abstract] [Full Text] [Related]
9. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease. Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Menezes MN; Guimarães T; Lima da Silva G; Francisco AR; Agostinho J; Santos L; Conceição I; Pinto FJ Amyloid; 2020 Sep; 27(3):174-183. PubMed ID: 32482106 [No Abstract] [Full Text] [Related]
10. Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis: Still Much to Learn. Alexander KM; Witteles RM JACC Cardiovasc Imaging; 2020 Jun; 13(6):1322-1324. PubMed ID: 31954652 [No Abstract] [Full Text] [Related]
11. What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers? Cho SG; Kim HY; Bom HS J Nucl Cardiol; 2021 Oct; 28(5):1958-1960. PubMed ID: 31768901 [No Abstract] [Full Text] [Related]
12. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of cardiac transthyretin amyloid load by [ Minutoli F; Laudicella R; Baldari S Amyloid; 2022 Sep; 29(3):210. PubMed ID: 35321592 [No Abstract] [Full Text] [Related]
14. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547 [TBL] [Abstract][Full Text] [Related]
15. Can Haq M; Pawar S; Berk JL; Miller EJ; Ruberg FL JACC Cardiovasc Imaging; 2017 Jun; 10(6):713-714. PubMed ID: 27568122 [No Abstract] [Full Text] [Related]
16. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study. Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346 [No Abstract] [Full Text] [Related]